PublishedJanuary 9, 2023 Category Partner News Spexis reports solid safety and pharmacokinetics results from first-in-human study with inhaled murepavadin, a novel macrocycle compound
PublishedNovember 2, 2022 Category Partner News First Patient Enrolled in Phase 2 Clinical Study Evaluating ARINA-1 for the Treatment of NCFBE
PublishedAugust 25, 2022 Category Partner News Savara Awarded Promising Innovative Medicine (PIM) Designation in the United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
PublishedAugust 3, 2022 Category Partner News Renovion Receives Notice of Study May Proceed Status for Lung Transplant Program
PublishedJuly 22, 2022 Category Publications Differential Performance and Lung Deposition of Levofloxacin with Different Nebulisers Used in Cystic Fibrosis.
